1. Home
  2. Cmax (pharmacology)
  Subject:

Cmax (pharmacology)   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Pharmacokinetics  14 times
Blood plasma  7 times
Bioavailability  6 times
Mass spectrometry  3 times
Ibuprofen  3 times
Enzyme inhibitor  3 times
Placebo  2 times
Phosphate  2 times
Paracetamol  2 times
Insulin  2 times
High-performance liquid chromatography  2 times
Diarrhea  2 times
Confidence interval  2 times
China  2 times
Biological half-life  2 times
Antibody  2 times
Zoonosis  1 time
Tumor necrosis factor superfamily  1 time
Transcriptome  1 time
Time point  1 time
Subcutaneous injection  1 time
Stomatitis  1 time
SPSS  1 time
Proteinuria  1 time
Progression-free survival  1 time
Praziquantel  1 time
Polystyrene  1 time
Polymer  1 time
Plateau  1 time
Phenotype  1 time
Pharmacodynamics  1 time
Parasitic disease  1 time
PH  1 time
Neutropenia  1 time
Mutation  1 time
Monte Carlo method  1 time
Metabolite  1 time
Messenger RNA  1 time
Mechanistic target of rapamycin  1 time
Mathematical optimization  1 time
MAP2K1  1 time
Irinotecan  1 time
Immune receptor  1 time
Illumina dye sequencing  1 time
Hypertension  1 time
Homeostasis  1 time
Hepatotoxicity  1 time
Hepatocyte  1 time
Hepatitis C virus  1 time
Glucose  1 time
Gene  1 time
Fusion protein  1 time
Folinic acid  1 time
Fluorouracil  1 time
Fasting  1 time
Everolimus  1 time
Etanercept  1 time
Estrogen receptor  1 time
Estradiol  1 time
Escherichia coli  1 time
Enantiomer  1 time
Echinococcus  1 time
Dog  1 time
Diabetes mellitus  1 time
Coumarin  1 time
Colorectal cancer  1 time
Clostridium  1 time
ClinicalTrials.gov  1 time
Clinical trial  1 time
Ciclosporin  1 time
Cholestasis  1 time
Chemotherapy  1 time
Cestoda  1 time
Caffeine  1 time
CYP2C19  1 time
Artificial intelligence  1 time
Analysis of variance  1 time
Aflibercept  1 time
Acid  1 time
ABCG2  1 time

Publications tagged with this subject: 17

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Pharmacokinetics of dimemorfan phosphate tablets in healthy Chinese volunteers

2. Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation

3. A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes

4. A phase I and pharmacokinetic study of afilbercept with FOLFIRI: comparison of Chinese and Caucasian populations

5. No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel

6. Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions

7. Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers

8. Pharmacokinetics and immunogenicity of T0001, a newly developed anti-TNFα fusion protein, in healthy volunteers

9. Pharmacokinetics and pharmacogenetics of the MEK1/2 inhibitor, selumetinib, in Asian and Western healthy subjects: a pooled analysis

10. Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus)

11. In vitro and in vivo evaluation of single-unit commercial conventional tablet and sustained-release capsules compared with multiple-unit polystyrene microparticle dosage forms of ibuprofen

12. Slow-release praziquantel for dogs: presentation of a new formulation for echinococcosis control

13. Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes

14. Comparative pharmacokinetics of three phenylpropanoids in rat plasma after oral administration of Ramulus Cinnamomi and Ramulus Cinnamomi-Ephedrae Herba herb-couple extract

15. A phase 1 study of the pharmacokinetics of nucleoside analog trifluridine and thymidine phosphorylase inhibitor tipiracil (components of TAS-102) vs trifluridine alone

16. Does the placebo effect modulate drug bioavailability? Randomized cross-over studies of three drugs

17. A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies


Questions?

Drop us a message.